Where does Lansinoh Laboratories, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lansinoh Laboratories, Inc. ranks #21,366 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lansinoh Laboratories, Inc. hold?

Lansinoh Laboratories, Inc. holds 13 US utility patents granted between 2018 and 2024, spanning 5 technology areas.

What is Lansinoh Laboratories, Inc.'s Innovation Score?

Lansinoh Laboratories, Inc. has an Innovation Score of 35.5 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Lansinoh Laboratories, Inc.'s patent grant rate increasing or decreasing?

Lansinoh Laboratories, Inc.'s recent grant velocity is +233% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Lansinoh Laboratories, Inc.'s patents?

Lansinoh Laboratories, Inc.'s patents average 11.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lansinoh Laboratories, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lansinoh Laboratories, Inc.

Q: What technology areas does Lansinoh Laboratories, Inc. focus on?

Lansinoh Laboratories, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 11 patents, ranking #638 of 3,490 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lansinoh ranks #21,366 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#21,366
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.5/100): 11.3
avg claims per patent: +233%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21366 · US Corporation #21,366 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,366/49,997
PHOTO-FINISH Lakeshore Learning…
CPC-NARROW A61M · 5 areas
INNOV-THIN 35.5/100
CLAIMS-PAR 11.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +233% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lakeshore Learning Materials, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lansinoh’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (26%) Velocity 11.7 pts (33%) Breadth 7.9 pts (22%) Claim depth 6.8 pts (19%)

Qualcomm Incorporated · highest

85
Eberhard Karls… · near

35
Chaoyang Semiconduct… · near

35
GCX · near

35
Lansinoh Laboratories · this assignee

35
TRW Vehicle Safety… · near

35
3D Lighting… · lowest

7

What this shows Lansinoh's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lansinoh?

Each dot is one of Lansinoh’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lansinoh’s own 11.3 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Lansinoh vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lansinoh's grants concentrate

Lansinoh Laboratories, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 84.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2019. By volume, Lansinoh sits between LSP Technologies, Inc. and Life Edit Therapeutics, Inc..

Lansinoh's three-year grant acceleration

Lansinoh Laboratories, Inc. shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

LSP

13
Lavit Technology

13
Lakeshore Learnin…

13
Lakewood Amedex

13
Lavazza Professio…

13
Lead Discovery Ce…

13
Life Detection

13
Life Edit Therape…

13
Lansinoh Laborato… ◀

13

What this shows Lansinoh holds 13 patents at rank #21,386, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lansinoh

By rank, the assignees closest to #21,386 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Lansinoh's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lansinoh, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Lansinoh ranks #638 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

GCX Corporation 35 Chaoyang Semiconductor Jiangyin Technology Co., Ltd. 35 TRW Vehicle Safety Systems Inc. 35 Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet 35

Lansinoh's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Lansinoh Laboratories, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	15.4%
2019	1	7.7%
2020	2	15.4%
2021	1	7.7%
2022	5	38.5%
2024	2	15.4%

Which technologies does Lansinoh Laboratories, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lansinoh Laboratories, Inc.'s patent record in context - here's where to go next.

Lansinoh Laboratories, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 84.6% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #21,366 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lansinoh Laboratories, Inc. against LSP Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.